A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Clinical trial NCT04193527 · COMPLETED

Trial details

NCT number: NCT04193527
Sponsor: GE Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinsonian Syndrome Parkinson Disease(PD)Multiple System Atrophy (MSA)Progressive Supranuclear Palsy (PSP)Essential Tremor

Start date: 2020-06-28
Primary completion: 2021-12-20
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.